Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Polycystic Ovary Syndrome × Desogestrel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Infertility, Female 1

Interventions

Metformin 19 Letrozole 9 Clomiphene 5 dapagliflozin 4 Contraceptives, Oral 4 Chorionic Gonadotropin 4 cetrorelix 3 Liraglutide 3 Inositol 3 follitropin beta 2 follitropin alfa 2 drospirenone and ethinyl estradiol combination 2 Musculoskeletal Manipulations 2 Glycoprotein Hormones, alpha Subunit 2 DLBS3233 2 Cholecalciferol 2 semaglutide 1 lime 1 follicle stimulating hormone, human, with HCG C-terminal peptide 1 drospirenone 1 cinnulin PF 1 Urofollitropin 1 Triptorelin Pamoate 1 Treatment Expectations 1 Thioctic Acid 1 Tablets 1 Sperm Injections, Intracytoplasmic 1 Sodium-Glucose Transporter 2 Inhibitors 1 Simvastatin 1 Resistance Training 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03197077 2023-04-07

Elonva_IVM

Universitair Ziekenhuis Brussel

Phase 3 Completed

Infertility, Female, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡